Chris Thomas is a Senior Principal Research Scientist at Abbott, where he plays a pivotal role in the Volwiler Society, a prestigious group dedicated to advancing scientific innovation within the company. With a career focused on revolutionizing diabetes care, Chris has dedicated his expertise to...
Chris Thomas is a Senior Principal Research Scientist at Abbott, where he plays a pivotal role in the Volwiler Society, a prestigious group dedicated to advancing scientific innovation within the company. With a career focused on revolutionizing diabetes care, Chris has dedicated his expertise to the commercialization of sensor-based interstitial glucose measurement technologies. His work is instrumental in transforming how individuals manage their diabetes, moving beyond traditional methods to more sophisticated, real-time monitoring solutions that significantly enhance patient outcomes.
At Abbott, Chris leads key projects that leverage his extensive knowledge in R&D, electrochemistry, and biosensor technology. His innovative approach combines microfluidics and solid-state lasers to develop next-generation wearables that not only improve accuracy but also enhance user experience. By integrating advanced inkjet printing techniques into the design of these devices, Chris ensures that they are not only effective but also cost-efficient, making them accessible to a broader population.
Chris’s commitment to improving lives is evident in his relentless pursuit of excellence in laboratory design and process engineering. His contributions have set new standards in the medical devices industry, particularly in the realm of diabetes management. As he continues to push the boundaries of what is possible in glucose monitoring, Chris remains dedicated to his mission of changing the standard of care for people with diabetes, ensuring that every innovation he develops is a step toward a healthier future for patients worldwide.
